Mesoblast Limited

Research Mesoblast Limited (LWB) on Bullrun: market cap EUR 1.52B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLWB
• ExchangeF
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 1.52B
• Financial periodFY2025
• RevenueEUR 17.20M
• Revenue growth191.4%
• Net income-EUR 102.14M
• Free cash flow-EUR 50.68M
• Gross margin70.2%

Valuation Snapshot

latest market cap is EUR 1.52B.

About Mesoblast Limited

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.

Frequently asked questions

What is Mesoblast Limited's market cap?

Mesoblast Limited's market capitalization is EUR 1.52B.

What does Mesoblast Limited do?

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.